H.U. Group Holdings, Inc. (TYO:4544)
Japan
· Delayed Price · Currency is JPY 3,010.00
-39.00 (-1.28%)
Jun 3, 2025, 1:43 PM JST
H.U. Group Holdings Revenue
In the fiscal year ending March 31, 2025, H.U. Group Holdings had annual revenue of 243.03B JPY with 2.56% growth. H.U. Group Holdings had revenue of 60.98B in the quarter ending March 31, 2025, with 2.59% growth.
Revenue
243.03B
Revenue Growth
+2.56%
P/S Ratio
0.71
Revenue / Employee
45.90M
Employees
5,295
Market Cap
173.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 243.03B | 6.08B | 2.56% |
| Mar 31, 2024 | 236.95B | -23.96B | -9.18% |
| Mar 31, 2023 | 260.91B | -12.04B | -4.41% |
| Mar 31, 2022 | 272.94B | 49.93B | 22.39% |
| Mar 31, 2021 | 223.02B | 34.30B | 18.18% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |